These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22925041)

  • 21. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.
    Maes M; Kubera M; Leunis JC; Berk M; Geffard M; Bosmans E
    Acta Psychiatr Scand; 2013 May; 127(5):344-54. PubMed ID: 22900942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1beta mediates the memory impairment associated with a delayed type hypersensitivity response to bacillus Calmette-Guérin in the rat hippocampus.
    Palin K; Bluthé RM; Verrier D; Tridon V; Dantzer R; Lestage J
    Brain Behav Immun; 2004 May; 18(3):223-30. PubMed ID: 15050649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.
    Leonard B; Maes M
    Neurosci Biobehav Rev; 2012 Feb; 36(2):764-85. PubMed ID: 22197082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.
    McNamee EN; Ryan KM; Kilroy D; Connor TJ
    Eur J Pharmacol; 2010 Jan; 626(2-3):219-28. PubMed ID: 19818755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
    Maes M; Fišar Z; Medina M; Scapagnini G; Nowak G; Berk M
    Inflammopharmacology; 2012 Jun; 20(3):127-50. PubMed ID: 22271002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils.
    Langereis JD; Oudijk EJ; Schweizer RC; Lammers JW; Koenderman L; Ulfman LH
    Eur Respir J; 2011 Feb; 37(2):406-15. PubMed ID: 20650986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression.
    Goshen I; Kreisel T; Ben-Menachem-Zidon O; Licht T; Weidenfeld J; Ben-Hur T; Yirmiya R
    Mol Psychiatry; 2008 Jul; 13(7):717-28. PubMed ID: 17700577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is IL-1 a good therapeutic target in the treatment of arthritis?
    Burger D; Dayer JM; Palmer G; Gabay C
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):879-96. PubMed ID: 16980212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
    Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):784-94. PubMed ID: 20609377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex.
    McNamee EN; Griffin EW; Ryan KM; Ryan KJ; Heffernan S; Harkin A; Connor TJ
    Neuropharmacology; 2010; 59(1-2):37-48. PubMed ID: 20361987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia.
    Girard S; Kadhim H; Larouche A; Roy M; Gobeil F; Sébire G
    Cytokine; 2008 Jul; 43(1):54-62. PubMed ID: 18511291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice.
    Huang FY; Chan AO; Lo RC; Rashid A; Wong DK; Cho CH; Lai CL; Yuen MF
    Eur J Cancer; 2013 Aug; 49(12):2760-70. PubMed ID: 23664095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.
    Maedler K; Sergeev P; Ehses JA; Mathe Z; Bosco D; Berney T; Dayer JM; Reinecke M; Halban PA; Donath MY
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8138-43. PubMed ID: 15141093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma.
    Bartfai T; Sanchez-Alavez M; Andell-Jonsson S; Schultzberg M; Vezzani A; Danielsson E; Conti B
    Ann N Y Acad Sci; 2007 Oct; 1113():173-7. PubMed ID: 17656565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures.
    Hailer NP; Vogt C; Korf HW; Dehghani F
    Eur J Neurosci; 2005 May; 21(9):2347-60. PubMed ID: 15932594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
    Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
    Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.